Listen to The Lancet Oncology

Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017 29.06.2017 7:34 ↓

Percy Lee discusses the impact of prior radiotherapy on the efficacy of pembrolizumab when used to treat non-small cell lung cancer.

EANO and palliative care: The Lancet Oncology: June 2, 2017 03.06.2017 8:57 ↓

Martin Taphoorn outlines the importance of palliative care for patients with gliomas.

Head and neck cancer Series: The Lancet Oncology: April 26, 2017 26.04.2017 17:04 ↓

Sandro Porceddu discusses the new  Lancet Oncology Series on head and neck cancer.  

¹⁸F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017 30.03.2017 5:57 ↓

Michele Cavo discusses the International Myeloma Working Group’s recommendations on the use of 18 F-FDG PET/CT for patients with multiple myeloma and other plasma cell dyscrasias.

Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017 02.03.2017 18:17 ↓

Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials.

Genomic modelling for radiation dosage: The Lancet Oncology: Feb 1 2017 02.02.2017 15:46 ↓

Javier Torres-Roca and Louis Harrison join us to discuss their work on genome modelling and its uses in calculating the appropriate radiation dosage.

Cancer survivorship in the USA: The Lancet Oncology: 30 December 30.12.2016 11:22 ↓

Ann Partridge talks about cancer survival in the USA.

Non-small cell lung cancer: The Lancet Oncology and The Lancet Respiratory Medicine: November 4, 2016 05.11.2016 13:15 ↓

Rafael Rossell discusses RET inhibitors and non-small cell lung cancer.

Quality of life and low-grade glioma: The Lancet Oncology: 31 October, 2016 31.10.2016 11:23 ↓

Brigitta Baumert discusses her article on quality of life in patients with high-risk, low-grade glioma.

Renal surveillance: The Lancet Oncology: August 30, 2016 01.09.2016 9:54 ↓

Brian Rini discusses active surveillance for patients with metastatic renal cell carcinoma.

Multiple myeloma: The Lancet Oncology: July 26, 2016 27.07.2016 10:45 ↓

Shaji Kumar discusses updated consensus criteria from the International Myeloma Working Group for response and minimal residual disease assessment in multiple myeloma.

HPV vaccination in Japan: The Lancet Oncology: June 28, 2016 30.06.2016 15:42 ↓

Catherine Sauvaget and Ryo Konno discuss Japan’s low uptake of screening programmes for breast and cervical cancer.

Antibody-drug conjugates for cancer therapy: The Lancet Oncology: June 01, 2016 02.06.2016 9:18 ↓

Anish Thomas discusses use of antibody-drug conjugates for cancer therapy.

Ethical issues in paediatric oncology trials: The Lancet Oncology: April 26, 2016 27.04.2016 15:11 ↓

Jean-Claude Dupont and François Doz discuss ethical issues in paediatric oncology clinical trials.

Medulloblastoma: The Lancet Oncology: March 11, 2016 12.03.2016 9:57 ↓

Michael Taylor discusses treatment approaches to the rare brain tumour that generally affects children, medulloblastoma.

NAB-paclitaxel and breast cancer: The Lancet Oncology: February 8, 2016 11.02.2016 8:45 ↓

Sibylle Loibl discusses the findings and clinical implications of the GeparSepto trial.

Rare cancers: The Lancet Oncology | February 2, 2016 03.02.2016 9:27 ↓

Dr. Richard Carvajal discusses aspects of treatment and research for rare cancers.

Mantle-cell lymphoma: The Lancet Oncology: January 2016 24.12.2015 16:10 ↓

Discussion of two new treatment approaches to indolent lymphoma and mantle-cell lymphoma, haematological diseases with generally poor response to chemotherapy.

Neuro-oncology: The Lancet Oncology, November 2015 02.11.2015 5:16 ↓

Hideho Okada discusses immunotherapy response assessment criteria in neuro-oncology. 

Metastatic breast cancer: The Lancet Oncology: Sept 10, 2015 10.09.2015 8:43 ↓

Rajendra Badwe discusses treatment options for metastatic breast cancer.

Breast cancer: The Lancet Oncology: Aug 6, 2015 11.08.2015 10:55 ↓

Harry Bear discusses the use of adjuvant and neoadjuvant bevacizumab in the treatment of early breast cancer.

Watchful waiting for patients with rectal cancer: The Lancet Oncology: July 6, 2015 07.07.2015 16:37 ↓

Ane Appelt discusses adopting a watchful waiting approach for patients with rectal cancer who achieved a clinical complete response after chemoradiotherapy.

HPV vaccine dosing schedules: The Lancet Oncology: June 10, 2015 10.06.2015 7:21 ↓

Amy Kreimer discusses HPV vaccine dosing schedules and cervical cancer prevention.

RANO Group: The Lancet Oncology: May 28, 2015 28.05.2015 11:47 ↓

Nancy Lin discusses RANO Group’s new response assessment criteria checklist.

HPV and cancer: The Lancet Oncology: April 30, 2015 30.04.2015 17:39 ↓

Rolando Herrero summarises three papers that constitute the HPV and cancer Series.